Bieche We, Parfait B, Tozlu S, Lidereau R, Vidaud M: Quantitation off androgen receptor gene expression inside the sporadic nipple cancers by real-date RT-PCR: proof you to MYC is an enthusiastic AR-managed gene. Carcinogenesis. 2001, twenty two (9): 1521-1526. /carcin/twenty two.9.1521.
Bratthauer GL, Lininger RA, Man YG, Tavassoli FA: Androgen and you will the hormone estrogen receptor mRNA condition in apocrine carcinomas. Diagn Mol Pathol. 2002, 11 (2): 113-118. 9606-200206000-00008.
Gatalica Z: Immunohistochemical studies of apocrine breast sores. Uniform over-phrase out-of androgen receptor accompanied by the increasing loss of estrogen and you will progesterone receptors when you look at the apocrine metaplasia and you may apocrine carcinoma into the situ. Pathol Res Pract. 1997, 193 (11-12): 753-758.
In the morning J Clin Pathol
Soreide JA, Lea OA, Varhaug JE, Skarstein A beneficial, Kvinnsland S: Androgen receptors from inside the operable breast cancer: regards to other steroid hormonal receptors, correlations so you can prognostic factors and you can predictive worth to own aftereffect of adjuvant tamoxifen medication. Eur J Surg Oncol. 1992, 18 (2): 112-118.
Bayer-Garner IB, Smoller B: Androgen receptors: a marker to improve susceptibility to have pinpointing cancer of the breast into the body metastasis of not familiar pri, thirteen (2): 119-122. /modpathol.3880021.
Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM: Matrix metalloproteinases: biologic passion and you will scientific implications. J Clin Oncol. 2000, 18 (5): 1135-1149.
Pang ST, Flores-Morales A great, Skoog L, Chuan YC, Nordstedt Grams, Pousette Good: Regulation away from matrix metalloproteinase thirteen phrase by androgen inside the prostate cancers. Oncol Agent. 2004, eleven (6): 1187-1192.
Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ: Androgen receptors in breast cancer. Cancer. 1984, 54 (11): 2436-2440. -0142(19841201)<2436::AID-CNCR2820541121>3.0.
Schippinger W, Regitnig P, Dandachi N, Wernecke KD, Bauernhofer T, Samonigg H, Moinfar F: Research of your own prognostic importance of androgen receptor expression when you look at the metastatic cancer of the breast. Virchows Arc. 2006, 449 (1): 24-30. /s00428-006-0213-six.
Parker RL, Huntsman DG, Lesack DW, Cupples JB, Give DR, Akbari Meters, Gilks CB: Evaluation regarding interlaboratory type about immunohistochemical determination regarding estrogen receptor standing using a breast cancer tissues microarray. 2002, 117 (5): 723-728. /PEF8-GL6F-YWMC-AG56.
Vizoso FJ, Gonzalez LO, Corte MD, Rodriguez JC, Vazquez J, Lamelas ML, , Garcia-Muniz JL: Study of matrix metalloproteinases and their inhibitors inside the breast cancer. Br J Disease https://www.datingranking.net/tr/mamba-inceleme. 2007, 96 (6): 903-911. /sj.bjc.6603666.
Narita D, Raica M, Suciu C, Cimpean An effective, Anghel A: Immunohistochemical expression away from androgen receptor and you will prostate-certain antigen within the cancer of the breast. Folia Histochem Cytobiol. 2006, forty-two (3): 165-172.
Egeblad Yards, Werb Z: The fresh functions for the matrix metalloproteinases from inside the disease evolution. Nat Rev Cancer. 2002, 2 (3): 161-174. /nrc745.
Turk V, Kos J, Turk B: Cysteine cathepsins (proteases)–into the fundamental phase of disease?. Cancer tumors Cellphone. 2004, 5 (5): 409-410. /S1535-6108(04)00117-5.
Manes S, Llorente M, Lacalle RA, Gomez-Mouton C, Kremer L, Mira Age, Martinez Air conditioning: New matrix metalloproteinase-nine regulates the fresh new insulin-like progress factor-triggered autocrine reaction when you look at the DU-145 carcinoma tissue. J Biol Chem. 1999, 274 (11): 6935-6945. /jbc..
Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel Age, Matrisian LM, Mareel Yards: Release of an invasion promoter Age-cadherin fragment from the matrilysin and stromelysin-step 1. J Cell Sci. 2001, 114 (Pt 1): 111-118.
Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM: Matrilysin [MMP-7] phrase chooses getting structure with reduced sensitiveness so you’re able to apoptosis. Neoplasia. 2001, step three (6): 459-468. /sj.neo.7900190.
CO;2-H
Stetler-Stevenson WG: Matrix metalloproteinases into the angiogenesis: a moving address to have healing intervention. J Clin Dedicate. 1999, 103 (9): 1237-1241. /JCI6870.
Cornelius Los angeles, Nehring LC, Harding Age, Bolanowski M, Welgus HG, Kobayashi DK, Pierce RA, Shapiro SD: Matrix metalloproteinases make angiostatin: outcomes on the neovascularization. J Immunol. 1998, 161 (12): 6845-6852.
Jiang Y, Goldberg ID, Shi YE: Complex jobs out-of cells inhibitors of metalloproteinases in cancer tumors. Oncogene. 2002, 21 (14): 2245-2252. /sj.onc.1205291.